Marrakesh, Morocco • 29-31 October 2018



There is a critical need to address the threat posed by antimicrobial resistance (AMR) to human, animal and environmental health. The significant scientific, economic and social challenges posed by AMR are now widely recognised by governments, the private sector, academia, organisations representing civil society, and increasingly consumers. Strong multisectoral collaboration at an intergovernmental level has been instrumental in elevating awareness and initiating coordinated action.

The Tripartite, a partnership between the OIE, the Food and Agriculture Organization of the United Nations (FAO), and the World Health Organization (WHO), has for many years worked together towards harmonised international standards, capacity building initiatives, and monitoring and evaluation to support responsible and prudent use of antimicrobials. In 2015, the Global Action Plan on Antimicrobial Resistance (AMR) was unanimously endorsed by the Membership of the three organisations, outlining the responsibilities of all stakeholders across sectors in combatting this global issue through a “One Health” approach. The Tripartite also promotes a “One Health” approach through the activities of the Interagency Coordination Group on Antimicrobial Resistance, formed by the United Nations in 2016.

Antimicrobials agents are essential tools for protecting animal health and welfare. They also contribute to satisfying the increasing world demand for safe and humanely produced food of animal origin. To ensure sustainability of livestock production and maintenance of animal welfare for terrestrial and aquatic animals, the efficacy of antimicrobial agents must be preserved through their responsible and prudent use. As the recognised global leader on animal health and welfare, the OIE engages in the fight against antimicrobial resistance through standard setting for and capacity building of Veterinary Services, livestock producers, and other stakeholders of the animal production industry. These activities are outlined in the four objectives of The OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials, and reflect the principles of the Global Action Plan on AMR. The objectives are: 1) Improve awareness and understanding; 2) Strengthen knowledge through surveillance and research; 3) Support good governance and capacity building; 4) Encourage implementation of international standards.

Following the first OIE Global Conference on the Responsible and Prudent Use of Antimicrobial Agents for Animals (13-15 March 2013), recommendations of this important meeting led directly to continued capacity building in Member Countries through the OIE PVS pathway, strengthened collaboration with WHO and FAO through the tripartite alliance, and the creation of the first global database on the use of antimicrobial agents in animals.

Since this time, OIE monitoring activities have demonstrated impressive progress in its Member Countries towards combatting AMR in animals. In 2012, an OIE questionnaire showed that 27% of the 152 responding Member Countries had an official system in place for collecting quantitative data on antimicrobial agents used in animals. By the second phase of the OIE data collection on antimicrobial agents intended for use in animals, concluded in May 2016, 73% (107 out of 146 countries that replied) were able to provide quantitative data on antimicrobial agents intended for use in animals.

The results of Technical Item 1 of the 85th OIE General Session in 2017, ‘Global action to alleviate the threat of antimicrobial resistance: progress and opportunities for future activities under the ‘One Health’ initiative’ also highlighted areas of development in Member Countries. The percentage of Member Countries declaring no significant awareness-raising activities on AMR fell from 46% (before 2015) to 22% (after 2015). The proportion of Member Countries reporting no data collection on antimicrobial use in animals fell from 31% to 19% after 2015. In the same period, the proportion of Member Countries without a regular national AMR surveillance system or plan fell from 44% to 25%. Only 7% of reporting countries declared not having put in place any policy or legislation on the quality, efficacy and safety of medicinal products, and an increase was shown in use of OIE international standards and guidelines on antimicrobials across all OIE Regions.

These remarkable improvements demonstrate the significant impact a harmonised intergovernmental approach can achieve in tackling this global issue, while also highlighting areas where future growth is needed. Current work on antimicrobial resistance focuses primarily on antibiotics, while data shows that resistance to antiparasitics is of growing concern to animal health, welfare and productivity. Country reporting in monitoring and evaluation by the OIE and its Tripartite partners has also underscored the problem of substandard and falsified veterinary antimicrobials, which escape government regulation and surveillance aimed at reducing development of antimicrobial resistance, and with unknown contents, pose a risk to animal and human health.

To ensure a successful, harmonised and sustained response to antimicrobial resistance, international standards must be implemented at all levels, and in all areas regarding animal health and production. As Member Countries work to implement OIE standards nationally, engagement is essential from all stakeholders, such as the veterinary pharmaceutical industry, wholesale and retail distributors of veterinary antimicrobials, animal feed manufacturers, and veterinarians and food animal producers in the field. Achieving agreement and collaboration between these diverse and relevant stakeholders is the next step in capacity building on a national level.

To achieve measurable results at the global, regional and at country levels, the OIE and Member Countries should ensure strong engagement and communication between, and training of, these different sectors of the animal health industry. Within the animal health sector at a national level, a strong Veterinary Authority must ensure a comprehensive understanding and effective collaboration across the Veterinary Service, ensuring veterinarians, farmers, feed and pharmaceutical industries, are committed and engaged in the National Action Plan, each understanding their role, and are supported in developing the required competencies to achieve the shared goal of reducing development and spread of antimicrobial resistance. The Veterinary Service must build and sustain effective One Health partnerships at a national level.

Additionally, on an intergovernmental level, enhanced integration of the surveillance and monitoring activities of the three organisations of the Tripartite would also support a better understanding of how antimicrobials are consumed, and how resistance circulates within and between humans, animals and plants, and through food, water and the environment. Such understanding is necessary to inform areas for beneficial intervention strategies in the future, and measurement of their impacts.


Aim of the conference

The Second OIE Global Conference comes at a critical juncture in the fight against antimicrobial resistance. Member Countries have demonstrated an impressive commitment to development of national capacity in this effort in line with international standards. To build upon and further inform this momentum, the Second OIE Global Conference will bring together OIE Delegates and OIE National Focal Points for Veterinary Products, as well as experts, professionals, policy makers, international organisations and donors, with the aims to increase understanding of the current global situation on antimicrobial resistance in animals, and to develop recommendations for future sustained control of AMR while ensuring animal health, animal welfare, veterinary public health, and food security. Particularly, it will provide a forum to examine how to best support Member Countries in continued fulfilment of the objectives of the OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials, and the Global Action Plan on Antimicrobial Resistance.

The conference will in particular:

  • Inform on initiatives taken by the Tripartite and other international organisations involved in One Health projects to control AMR in humans, animals, plants, and the environment at national, regional and international levels;
  • present an overview of the progress achieved since the first OIE Global Conference on the Responsible and Prudent Use of Antimicrobial Agents for Animals in 2013 on antimicrobial use in animals including the OIE global database on antimicrobial agents intended for use in animals;
  • Promote implementation by all relevant stakeholders in OIE Member Countries of the OIE’s international standards and guidelines on the use of antimicrobial agents and antimicrobial resistance in animals, including the updated OIE List of Antimicrobial Agents of Veterinary Importance;
  • Support the ongoing development of comprehensive surveillance and monitoring systems for antimicrobial use and resistance appropriate to different national and regional contexts;
  • Encourage responsible and prudent use of veterinary antimicrobials in the field, including development of species-specific clinical guidelines, and engagement strategies for veterinarians and livestock producers;
  • Promote access to high quality veterinary products worldwide and strategies to reduce dissemination of falsified and substandard products;
  • Consider communication tools and interventions to generate key behavioural changes towards reducing use of antimicrobials in the field;
  • Inform on the research and possible implementation of alternatives to antimicrobial agents;
  • Discuss the development of guidance on the responsible and prudent use of antiparasitics;
  • Encourage international solidarity in supporting the OIE and its Member Countries to effectively implement the OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials.


Steering Committee

Dr Matthew Stone (World Organisation for Animal Health, OIE – Chair)

Dr Alain Dehove (OIE)

Dr Abderrahman El Abrak (Delegate of Morocco to the OIE – Office National de Sécurité Sanitaire des Produits Alimentaires – ONSSA)

Dr Elisabeth Erlacher-Vindel (OIE)

Dr Mara Gonzalez-Ortiz (OIE)

Dr Koen van Dyck (European Commission)

Scientific Committee

Dr Herbert Schneider (Scientific Committee Coordinator – Agrivet International Consultants, Namibia)

Dr Carolee Carson (Public Health Agency of Canada)

Dr Gérard Moulin (Agency for Food, Environmental and Occupational Health & Safety – ANMV/ANSES, France)

Dr Donald Prater (U.S. Food and Drug Administration)

Dr Masumi Sato (National Institute of Animal Health, Japan)

Dr Chris Teale (Animal and Plant Health Agency, UK)

Dr Jordi Torren Edo (European Medicines Agency – EMA)

Prof. Jacques Acar (Senior Expert – OIE)

Dr Elisabeth Erlacher-Vindel (OIE)

Dr Delfy Gochez (OIE)

Dr Awa Aidara-Kane (World Health Organisation – WHO)

Dr April Johnson (Food and Agriculture Organisation of the United Nations – FAO)

Dr Olivier Espeisse (HealthforAnimals)

Organising Committee

Dr Mara Gonzalez-Ortiz (Organising Committee Coordinator – OIE)

Dr Khadija Id Sidi Yahia (ONSSA)

Dr Rachid Bouguedour (OIE SRR Tunis)

Ms Nelly Dubarry (OIE)

Dr Margot Raicek (OIE)

Dr François Diaz (OIE)


Please click here to consult the Provisional Programme


The Speakers’ Biographies will soon be available



The Presentations will be made available on this page 15 days after the Conference


The Scientific Committee of the conference will select posters for presentation from submitted abstracts.


Please send abstracts no later than this deadline to

Abstracts will be reviewed by the Scientific Committee and their decision will be sent to authors by 2 July 2018. Please note that the authors of the selected posters will have to pay their registration fees.

Posters should address one or several objectives of the Global Conference on Antimicrobial Resistance and Prudent Use of Antimicrobial Agents in Animals: “Putting Standards into Practice”, and should be closely linked with the theme of a specific session.

Please refer to the objectives and sessions of the conference above.

Abstract Guidelines:

  1. Abstracts should be written in British English (UK), and should be submitted as a Microsoft Word file. Abstracts should clearly indicate the objectives of the study or programme, methods used, results obtained, and a brief discussion and conclusion.
  2. The total number of words in the body of the abstract, including references, should not exceed 300.
  3. Use upper case/bold for title. The name(s) of the author(s) should be written as follows: the first name(s) and the surname(s). Do not indicate academic titles/degrees of authors. If there is more than one author, please underline the name of the presenting author. Provide a detailed address, including country, for each author. Where there are several authors and they are from several establishments, please link authors/addresses using superscript numbers.Example showing layout of abstract (Use Arial, 10 point font)

(Title; Use bold type)

(Leave two lines blank after title)

John Smith1 & Manuel Rodriguez2 (Authors; first name and surname, Name of the speaker should be underlined)

1 Affiliations, Name of the institution, City, Country

2 Affiliations, Name of the Institution, City, Country

(Leave two lines blank before the beginning of the main text of the abstract)

Text of the abstract……….

Note: The Poster Session is designed for educational and informational purposes only. It is not to be used for any commercial purposes.

Following selection of an abstract for presentation, please use the following guidelines for poster preparation:

  1. The poster board should measure approx. 1.2 m (47.24 in) high x 0.9 m (35.43 in) wide and be made of material that will accept double-sided tape (to be supplied by the Conference organiser).
  2. Posters must be prepared and printed in advance and should be large enough to be viewed from a distance of one meter (approx. 3 feet).
  3. Posters should have a label at the top showing the title of the paper, the name(s) of the author(s) and their affiliation(s). The size of the characters for the title should be at least 2.5 cm (approx. 1 inch) high. Posters should only be prepared in English.
  4. Illustrations, tables and charts should be clear and simple.
  5. Authors will be asked to mount their poster on the morning of 29 October and remove it after the last session of the conference.


The Posters will be made available on this page 15 days after the Conference


The Book of Abstracts will be made available on this page 15 days after the Conference


The Recommendations will be made available on this page 15 days after the Conference


The List of Participants will be made available on this page 15 days after the Conference



Information about Visa will soon be available


Palais des Congrès de la Palmeraie
Palmeraie Resorts
Circuit de la Palmeraie
BP 1488, 40000 Marrakesh, Morocco


Information about Accomodation will soon be available


Information about Transportation will soon be available


Information about Morocco will soon be available


J. Acar & G. Moulin ; Ed.: 2012
ISBN 978-92-9044-875-4

Antimicrobial resistance in animal and public health, Scientific and Technical Review, Vol. 31 (1)
The focus of this  Review  is to address the various factors that must be taken into account when trying to understand the antimicrobial resistance problem, with a particular focus on the use of antimicrobials in animals.

OIE; Ed.: 2015
ISBN 978-92-95108-16-5

OIE Standards, Guidelines and Resolution on antimicrobial resistance and the use of antimicrobial agents This special publication has been prepared to support the Global Action Plan on Antimicrobial Resistance (GAP-AMR) that WHO is developing in collaboration with FAO and OIE.

OIE; Ed.: 2014
ISBN 978-92-9044-955-3

Responsible and Prudent Use of Antimicrobial Agents for Animals
International Solidarity to fight against Antimicrobial Resistance This booklet in English gives a summary of the presentations made at this important global conference and includes the recommendations adopted by the Scientific Committee of the conference and all its participants.



First and second OIE Annual reports on the use of antimicrobial agents in animals

The OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials
Animal health and welfare depend on the availability, effectiveness, and appropriate use of quality antimicrobial products. The OIE has published its Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials to tackle the antimicrobial resistance threat.

Antimicrobial resistance factsheet


Antimicrobial Resistance (AMR)

The OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials

Responsible and prudent

use of antibiotics

Handle Antimicrobials with care Tripartite Infographic


Information about Media Center will soon be available


Conference Secretariat

World Organisation for Animal Health (OIE)

12 rue de Prony, 75017 Paris


Tel: 33 (0) 1 44 15 18 65

Fax: 33 (0) 1 42 67 09 87



Organised with the financial support from the Kingdom of Morocco, the European Union, the People’s Republic of China, France, Italy, and the United Kingdom Fleming Fund. The OIE would also like to thank the Kingdom of Morocco for its significant support in organising this conference.